WA
GEVA

Waverly Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Waverly Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$10K – 434
2015
Q1 		$10K Hold
100
– – 0.01% 268
2014
Q4 		$9K Hold
100
– – ﹤0.01% 335
2014
Q3 		$7K Hold
100
– – ﹤0.01% 577
2014
Q2 		$10K Hold
100
– – ﹤0.01% 456
2014
Q1 		$8K Hold
100
– – ﹤0.01% 481
2013
Q4 		$6K Hold
100
– – ﹤0.01% 661
2013
Q3 		$6K Buy
+100
New +$4.92K ﹤0.01% 488

Waverly Advisors's GEVA Position: Q2 2015 in Review

Waverly Advisors sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 100 shares — an estimated $10K sold.

Waverly Advisors first reported a position in GEVA in Q3 2013 and held it in 7 quarters. The position peaked at $10K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Waverly Advisors reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Waverly Advisors sold 100 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $10K.
  • Waverly Advisors first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 7 quarters.
  • Waverly Advisors's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $10K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Waverly Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.